Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) ...

Solving society's problems with evidence is a work in progress, argues a must-read new book. The process is surprisingly new ...

The American Lung Association today announced the launch of the COPD-OMA trial, a national clinical research effort conducted through its Airways Clinical Research Centers (ACRC). The study will ...

Anxiety is one of the most widespread mental health challenges of our time. Anxiety disorders are highly prevalent ...

Self-help can feel overwhelming, but many techniques share the same underlying patterns. Here’s what we found after five ...

The agency’s scientists and data contractors reviewed millions of patient records for studies that were pulled back before ...

Suneel Kamath, MD, knows too well the sense of helplessness that comes with living through what he calls “the doughnut hole.” ...

An excerpt from Beyond Belief on building the evidence revolution in Washington ...

A randomized controlled trial correlates 4 weeks of probiotics to positive microstructure and function changes in several ...

The US Department of Justice's move to reclassify medical cannabis to Schedule III could unlock critical research ...

For premenopausal women with ER-positive early breast cancer, even if chemotherapy or tamoxifen are given, OFS significantly reduces the 15-year risk of recurrence and death.

But when visitors come to Brevard, there is something they won’t find — fluoride in the tap water. Maurice Jones, a former ...